Last reviewed · How we verify
Hyperbaric Lidocaine 5%
Hyperbaric Lidocaine 5% is a Small molecule drug developed by Universitas Sebelas Maret. It is currently FDA-approved. Also known as: Lidodex.
Hyperbaric Lidocaine 5% is a small molecule that blocks the sodium channel alpha subunit, classified as a blocker. It has been studied in clinical trials for use in anesthesia, including for procedures such as prostate cancer surgery and cystoscopy.
At a glance
| Generic name | Hyperbaric Lidocaine 5% |
|---|---|
| Also known as | Lidodex |
| Sponsor | Universitas Sebelas Maret |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Spinal Anesthesia For Enhanced Recovery After Liver Surgery (NA)
- Spinal Anesthesia for Robotic Assisted Laparoscopic Prostatectomy (PHASE4)
- Effect of Sedation After Ultrasound-Guided Spinal Anesthesia on Back Pain (NA)
- Effect of Intravenous or Intrathecal Dexmedetomidine on Bupivacaine Spinal Block in Lower Abdominal Surgery (PHASE2, PHASE3)
- Lumbar ESPB in Hip Replacement Surgery (NA)
- Efficacy and Safety of Prilocaine 2% and Lidocaine 5% Hyperbaric Against Spinal Anesthesia in Post Cystoscopy Procedure (PHASE4)
- Comparison of the Effects of Epidural Analgesia and Local Infiltrative Analgesia Methods on Pain Control (NA)
- Effect of Different Types of Anesthesia on Perioperative Brain Natriuretic Peptide Levels in Parturient Cardiac Patient Undergoing Elective Cesarean Section
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hyperbaric Lidocaine 5% CI brief — competitive landscape report
- Hyperbaric Lidocaine 5% updates RSS · CI watch RSS
- Universitas Sebelas Maret portfolio CI
Frequently asked questions about Hyperbaric Lidocaine 5%
What is Hyperbaric Lidocaine 5%?
Who makes Hyperbaric Lidocaine 5%?
Is Hyperbaric Lidocaine 5% also known as anything else?
What development phase is Hyperbaric Lidocaine 5% in?
Related
- Manufacturer: Universitas Sebelas Maret — full pipeline
- Also known as: Lidodex
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing